UTRN expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.637510E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.466360E-01
Normal-vs-Stage2
2.019600E-02
Normal-vs-Stage3
7.988200E-02
Normal-vs-Stage4
5.381400E-01
Stage1-vs-Stage2
9.517200E-01
Stage1-vs-Stage3
3.832200E-01
Stage1-vs-Stage4
1.960180E-01
Stage2-vs-Stage3
3.778400E-01
Stage2-vs-Stage4
1.152810E-01
Stage3-vs-Stage4
2.319600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.762200E-03
Normal-vs-AfricanAmerican
5.182200E-01
Normal-vs-Asian
4.910000E-02
Caucasian-vs-AfricanAmerican
3.408800E-01
Caucasian-vs-Asian
2.369800E-01
AfricanAmerican-vs-Asian
1.434620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.441700E-03
Normal-vs-Female
5.459900E-02
Male-vs-Female
7.816200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.011600E-01
Normal-vs-Age(41-60Yrs)
8.416300E-02
Normal-vs-Age(61-80Yrs)
9.700100E-03
Normal-vs-Age(81-100Yrs)
2.161600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.565800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.035600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.603200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.955700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.441900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.416200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.638200E-01
Normal-vs-Daily Drinker
1.808970E-01
Normal-vs-Weekly Drinker
6.969800E-02
Normal-vs-Occasional Drinker
4.070300E-02
Normal-vs-Social Drinker
2.925800E-01
Non Drinker-vs-Daily Drinker
2.626000E-02
Non Drinker-vs-Weekly Drinker
8.874000E-01
Non Drinker-vs-Occasional Drinker
8.281600E-01
Non Drinker-vs-Social Drinker
3.265000E-01
Daily Drinker-vs-Weekly Drinker
1.249010E-01
Daily Drinker-vs-Occasional Drinker
5.266100E-02
Daily Drinker-vs-Social Drinker
4.776200E-02
Weekly Drinker-vs-Occasional Drinker
9.671000E-01
Weekly Drinker-vs-Social Drinker
4.430400E-01
Occasional Drinker-vs-Social Drinker
4.027000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.337190E-01
Normal-vs-Grade 2
1.212800E-01
Normal-vs-Grade 3
9.432400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.733600E-01
Grade 1-vs-Grade 3
9.266000E-01
Grade 1-vs-Grade 4
1.337190E-01
Grade 2-vs-Grade 3
7.588400E-01
Grade 2-vs-Grade 4
1.212800E-01
Grade 3-vs-Grade 4
9.432400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.674010E-02
Normal-vs-NonDiabetic
9.138500E-03
Diabetic-vs-NonDiabetic
6.096800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.897230E-01
Normal-vs-NoPancreatitis
1.546290E-02
Pancreatitis-vs-NoPancreatitis
2.229700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.573900E-02
Normal-vs-N1
2.014200E-02
N0-vs-N1
7.865800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.892360E-01
Normal-vs-TP53-NonMutant
1.162210E-01
TP53-Mutant-vs-TP53-NonMutant
7.256300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
